230 related articles for article (PubMed ID: 21738816)
21. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
22. pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant.
Brunner A; Riss P; Heinze G; Brustmann H
Br J Cancer; 2012 Jun; 107(1):84-90. PubMed ID: 22644303
[TBL] [Abstract][Full Text] [Related]
23. Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining.
Terlikowski S; Sulkowski S; Lenczewski A; Musiatowicz B; Kulikowski M
Arch Gynecol Obstet; 1999 Nov; 263(1-2):29-33. PubMed ID: 10728625
[TBL] [Abstract][Full Text] [Related]
24. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Kuşku Cabuk F; Yığıt S; Demır L; Cakalağaoğlu F; Tarhan O
Turk Patoloji Derg; 2014; 30(1):30-7. PubMed ID: 24448704
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.
Anttila M; Kosma VM; Ji H; Wei-Ling X; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
J Clin Oncol; 1998 Aug; 16(8):2591-600. PubMed ID: 9704708
[TBL] [Abstract][Full Text] [Related]
26. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
Kalogeraki A; Tamiolakis D; Matalliotaki C; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Sinatkas V; Matalliotakis I
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
[TBL] [Abstract][Full Text] [Related]
27. Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.
Tracht J; Zhang K; Peker D
J Histochem Cytochem; 2017 Jul; 65(7):399-405. PubMed ID: 28651471
[TBL] [Abstract][Full Text] [Related]
28. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Yoshikawa K; Shimada M; Higashijima J; Nakao T; Nishi M; Takasu C; Kashihara H; Eto S; Bando Y
Anticancer Res; 2018 Mar; 38(3):1735-1739. PubMed ID: 29491110
[TBL] [Abstract][Full Text] [Related]
30. Predicting short-term recurrence in pituitary adenomas: Phosphohistone-H3 (Ser 10) proves an effective biomarker.
Li C; Wei L; Li L; Wang J; Li R; Zhang Q; Zhou D
Clin Neuropathol; 2020; 39(2):70-79. PubMed ID: 31724532
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
[TBL] [Abstract][Full Text] [Related]
32. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
[TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.
Goltz D; Montani M; Braun M; Perner S; Wernert N; Jung K; Dietel M; Stephan C; Kristiansen G
Pathology; 2015 Dec; 47(7):629-36. PubMed ID: 26517642
[TBL] [Abstract][Full Text] [Related]
34. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors].
Wang S; Ma XY; Xia Y; Zhang LH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study.
Habberstad AH; Gulati S; Torp SH
Diagn Pathol; 2011 May; 6():43. PubMed ID: 21609421
[TBL] [Abstract][Full Text] [Related]
36. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.
Draganova-Tacheva R; Bibbo M; Birbe R; Daskalakis C; Solomides C
Acta Cytol; 2013; 57(3):291-5. PubMed ID: 23635399
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of phospho-histone H3 in prostate carcinoma.
Nowak M; Svensson MA; Carlsson J; Vogel W; Kebschull M; Wernert N; Kristiansen G; Andrén O; Braun M; Perner S
World J Urol; 2014 Jun; 32(3):703-7. PubMed ID: 23887713
[TBL] [Abstract][Full Text] [Related]
38. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
[TBL] [Abstract][Full Text] [Related]
39. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
40. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
